Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study

Do immunosuppressive treatments influence immune responses against adenovirus-based COVID-19 vaccines in patients with multiple sclerosis? An Argentine multicenter study

IntroductionThere are no reports in LATAM related to longitudinal humoral and cellular response to adenovirus based COVID-19 vaccines in people with Multiple Sclerosis (pwMS) under different disease modifying therapies (DMTs) and neutralization of the Omicron and Wuhan variants of SARS-COV-2.Methods...

Full description

Bibliographic Details
Main Authors: Berenice Anabel Silva, Esteban Miglietta, Juan Cruz Casabona, Shirley Wenker, María Bárbara Eizaguirre, Ricardo Alonso, Magdalena Casas, Luciana Grimanesa Lázaro, Federico Man, Gustavo Portuondo, Abril Lopez Bisso, Noelia Zavala, Federico Casales, Gastón Imhoff, Dra Judith Steinberg, Pablo Adrián López, Edgar Carnero Contentti, Norma Deri, Vladimiro Sinay, Javier Hryb, Edson Chiganer, Felisa Leguizamon, Verónica Tkachuk, Johana Bauer, Flavia Ferrandina, Susana Giachello, Paula Henestroza, Orlando Garcea, Carla Antonela Pascuale, Mauro Heitrich, Osvaldo L. Podhajcer, Sabrina Vinzón, Tomas D’Alotto-Moreno, Alejandro Benatar, Gabriel Adrián Rabinovich, Fernando J. Pitossi, Carina C. Ferrari
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-08-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
vaccine
immune response
COVID - 19
cell response
Omicron (BA.1)
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1431403/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1431403/full

Similar Items